389 related articles for article (PubMed ID: 32607945)
1. Emerging Therapeutic Options for Chronic Pruritus.
Reszke R; Krajewski P; Szepietowski JC
Am J Clin Dermatol; 2020 Oct; 21(5):601-618. PubMed ID: 32607945
[TBL] [Abstract][Full Text] [Related]
2. Small molecule drugs for the treatment of pruritus in patients with atopic dermatitis.
Soeberdt M; Kilic A; Abels C
Eur J Pharmacol; 2020 Aug; 881():173242. PubMed ID: 32504692
[TBL] [Abstract][Full Text] [Related]
3. Itch Management: Treatments under Development.
Pereira MP; Ständer S
Curr Probl Dermatol; 2016; 50():71-6. PubMed ID: 27578074
[TBL] [Abstract][Full Text] [Related]
4. Drugs on the Horizon for Chronic Pruritus.
McEwen MW; Fite EM; Yosipovitch G; Patel T
Dermatol Clin; 2018 Jul; 36(3):335-344. PubMed ID: 29929605
[TBL] [Abstract][Full Text] [Related]
5. Novel drugs for the treatment of chronic pruritus.
Pereira MP; Ständer S
Expert Opin Investig Drugs; 2018 Dec; 27(12):981-988. PubMed ID: 30426802
[TBL] [Abstract][Full Text] [Related]
6. Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review.
Phan NQ; Lotts T; Antal A; Bernhard JD; Ständer S
Acta Derm Venereol; 2012 Sep; 92(5):555-60. PubMed ID: 22504709
[TBL] [Abstract][Full Text] [Related]
7. Chronic Pruritus: Current and Emerging Treatment Options.
Pereira MP; Ständer S
Drugs; 2017 Jun; 77(9):999-1007. PubMed ID: 28466423
[TBL] [Abstract][Full Text] [Related]
8. Medical treatment of pruritus.
Ständer S; Weisshaar E
Expert Opin Emerg Drugs; 2012 Sep; 17(3):335-45. PubMed ID: 22870909
[TBL] [Abstract][Full Text] [Related]
9. [Modern systemic therapy for pruritus].
Metz M; Pereira MP
Hautarzt; 2020 Jul; 71(7):518-524. PubMed ID: 32399670
[TBL] [Abstract][Full Text] [Related]
10. Antipruritic treatment with systemic μ-opioid receptor antagonists: a review.
Phan NQ; Bernhard JD; Luger TA; Ständer S
J Am Acad Dermatol; 2010 Oct; 63(4):680-8. PubMed ID: 20462660
[TBL] [Abstract][Full Text] [Related]
11. Itch Management: Systemic Agents.
Pongcharoen P; Fleischer AB
Curr Probl Dermatol; 2016; 50():46-53. PubMed ID: 27578071
[TBL] [Abstract][Full Text] [Related]
12. Substance P and neurokinin 1 receptor are new targets for the treatment of chronic pruritus.
Ständer S; Yosipovitch G
Br J Dermatol; 2019 Nov; 181(5):932-938. PubMed ID: 31016733
[TBL] [Abstract][Full Text] [Related]
13. Current treatment strategies in refractory chronic pruritus.
Pereira MP; Mittal A; Ständer S
Curr Opin Pharmacol; 2019 Jun; 46():1-6. PubMed ID: 30530232
[TBL] [Abstract][Full Text] [Related]
14. Current and emerging systemic treatments targeting the neural system for chronic pruritus.
Golpanian RS; Yosipovitch G
Expert Opin Pharmacother; 2020 Sep; 21(13):1629-1636. PubMed ID: 32515664
[TBL] [Abstract][Full Text] [Related]
15. Chronic pruritus: targets, mechanisms and future therapies.
Pogatzki-Zahn E; Marziniak M; Schneider G; Luger TA; Ständer S
Drug News Perspect; 2008 Dec; 21(10):541-51. PubMed ID: 19221635
[TBL] [Abstract][Full Text] [Related]
16. [Pruritus in systemic diseases : Common and rare etiologies].
Kremer AE; Mettang T
Internist (Berl); 2019 Aug; 60(8):814-820. PubMed ID: 31243493
[TBL] [Abstract][Full Text] [Related]
17. A New Generation of Treatments for Itch.
Fowler E; Yosipovitch G
Acta Derm Venereol; 2020 Jan; 100(2):adv00027. PubMed ID: 31940047
[TBL] [Abstract][Full Text] [Related]
18. Uremic pruritus.
Mettang T; Kremer AE
Kidney Int; 2015 Apr; 87(4):685-91. PubMed ID: 24402092
[TBL] [Abstract][Full Text] [Related]
19. Targeted treatment of pruritus: a look into the future.
Tey HL; Yosipovitch G
Br J Dermatol; 2011 Jul; 165(1):5-17. PubMed ID: 21219293
[TBL] [Abstract][Full Text] [Related]
20. Opioid-induced pruritus: an update.
Reich A; Szepietowski JC
Clin Exp Dermatol; 2010 Jan; 35(1):2-6. PubMed ID: 19663845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
